Finance

Lists
Q2 2027 earnings • released • EPS miss -1.92% • Revenue beat +1.68%
See results
APOLLOHOSP:NSE
Apollo Hospitals Enterprise Ltd
₹8,446.00
+0.90%
(+75.00) 1D
Nov 6, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APOLLOHOSP...
Open
₹8,356.00
High
₹8,481.00
Low
₹8,310.00
Mkt. cap
1.21T
Avg. vol.
675.27K
Volume
423.18K
Dividend
0.24%
Quarterly dividend
₹5.00
Ex-dividend date
Feb 16, 2026
P/E ratio
58.16
52-wk high
₹9,070.50
52-wk low
₹6,696.50
EPS
₹145.21
Shares outstanding
139.13M
No. of employees
44K
Open
₹8,356.00
High
₹8,481.00
Low
₹8,310.00
Mkt. cap
1.21T
Avg. vol.
675.27K
Volume
423.18K
Dividend
0.24%
Quarterly dividend
₹5.00
Ex-dividend date
Feb 16, 2026
P/E ratio
58.16
52-wk high
₹9,070.50
52-wk low
₹6,696.50
EPS
₹145.21
Shares outstanding
139.13M
No. of employees
44K
News stories
From web sources and news partners
Profile
Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the second largest for-profit private hospital network in India after Manipal Hospitals, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries. The company was founded by Prathap C. Reddy in 1983 as the first corporate healthcare provider in India. Several of Apollo's hospitals have been among the first in India to receive international healthcare accreditation by the United States based Joint Commission International as well as NABH accreditation. Apollo Hospitals and its subsidiaries have faced multiple allegations of overcharging, forceful transplants, and corruption. Wikipedia
About Apollo Hospitals Enterprise Ltd
CEO-
Employees44K
FoundedSep 18, 1983
Headquarters-
SectorHealth Care
IndustryHealth care provider
Last report
Nov 5, 2026
Fiscal period
Q2 2027
₹43.71 / ₹44.56
-1.92%miss
Revenue / Est. (INR)
76.15B / 74.89B
+1.68%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
64.77B
66.06B
70.44B
76.15B
Cost of goods sold
41.31B
45.90B
43.93B
48.25B
Cost of revenue
41.31B
45.90B
43.93B
48.25B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
6.12B
-
-
Operating expense
16.00B
12.18B
17.94B
18.30B
Total operating expenses
57.31B
58.09B
61.86B
66.54B
Operating income
7.46B
7.97B
8.57B
9.61B
Other non operating income
528.00M
-2.14B
488.00M
448.00M
EBT including unusual items
6.82B
7.22B
7.99B
9.03B
EBT excluding unusual items
7.01B
6.43B
7.99B
9.03B
Income tax expense
1.66B
1.70B
1.88B
2.45B
Effective tax rate
24.30%
23.58%
23.59%
27.11%
Other operating expenses
13.81B
3.82B
15.58B
15.99B
Net income
5.02B
5.29B
5.81B
6.30B
Net profit margin
7.75%
8.01%
8.24%
8.27%
Earnings per share
35.95
36.76
40.37
43.71
Interest and investment income
-
767.00M
-
-
Interest expense
-1.13B
-256.00M
-1.20B
-1.14B
Net interest expenses
-1.13B
511.00M
-1.20B
-1.14B
Depreciation and amortization charges
2.19B
2.24B
2.35B
2.30B
EBITDA
8.77B
9.37B
9.97B
11.87B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps